!"#$%&!&'()'*&$+,-./!*&'./0/(/1)&
!"#$%&'()*+$% ,-*.*%)/*$%01234
5230%$%06")7+$67"+
!"#$%&'()$(&' *+,-./%0,1,2,3./%/.+45-2,3./ 23456
(&$$6$%7#'$#88*()6"$
82306")7+$67"+ 9")7+$6:/*$%015;340
NADPH,H+NADP+Palmityl thioestérase
%7- %78 Acide palmitique &9)#' %(.
Elongases 7:41./;<341
Désaturases
HS- %(.'9:;66:9<=6
Δ2-énoyl-S- HS- Dernier tour +4;>='?@:6'6:<A@36
Acyl-S- +4;>=6'?@:6';96:<A@36 !")9) *+,-./%0,1,2,3./%+45=>?></ *+,-./%0,1,2,3./%@3,A2,3./
!*(<+/*$%0=<+0-*:*=<+ BCD4;9=
HS- >#*=<0(-?#$#@$-*A'<
β-hydroxyacyl-S-
*:CE9DFE+ >#*=<0#@$-*A'<
Acyl-S- >#*=<0/)'6$#@$-*A'< B9C9%D4,. .(.
NADP+CO2 Malonyl-S- $:A@;9= >#*=<0#@"%$="+$B?#@$-*A'<
HS- FGEC=6<3@EC
HS- FE+!% HS-
NADPH,H+β-cétoacyl-S- Acétyl-S-
CO2
1er tour Malonyl-S- +43<DCFE+ !HA:C59=
+4;>=6':I;936
FE+!% &<G:9EC
HS- /6EJ@59=6':4<;K36
Malonyl-S- 82145E74* F-7
ADP+Pi CO2 *3K:CE9:<=
+43<DCFE+ FE+!% +43<DCFE+ FE+!%
7#+(0LFE+!%
ATP + H2O 7M#+(0%N%LO
PE;='>=6'J=9<E6=6'JGE6JG:<= +43<DCFE+ +43<E:43<DCFE+ %*BFE+
!1>+4/. 0D@AK:<=
4GEC;9=
0GE6JG:<;>DC '63@;9= 2+(%7
3<G:CE9:I;9= #F
#+(%N%L&5/>1,5.%G !1>+2?45%H
QRGD>@ESDTA<D@:<=
FE+!%
4GEC;9= (%+0 *(I
#+(L
'63@;9= &5/>1,5.%H !1>+2?45%G
#+(%N%L7#F +43<DCFE+ FE+!% +43<DCFE+ FE+!% +43<DCFE+ CD@?=6$B?7'/?6)/<0=E
3<G:CE9:I;9= *8IHII,
#+(%N%L
#+(L+43<DCFE+ +43<E:43<DCFE+ %*BFE+ +43<E:43<:<=
FE+!% *+E174* FE+!% BCD43@EC0 F:@9;<;9= FE+!%
F"/$/@*$-)+< %7-
(;:4DC?CD43@ECR0 +4DC?CD43@ECR0 *+E174* +4DCFE+ F-7 +43<E9=
>#?-(-?#"6$-G0)#?-/6)%+H"6)+< I-?#"6$-G0)#?-/6)%+H"6)+< 2+( J@*$-)+< J6)%+H"6)+<
%7- *8IHII, FE+!% F:@9;<;9= >#?-F$>0=E FE+!% +43<DCFE+ +43<E:43<DCFE+ +43<E:43<:<=
FE+!% 2+(%7
#+(%N%L
G@$+:@)/)+< *(I U7R39EDCFE+ FE+!%
+4;>='?@:6 BCD43@EC QR43<E:4DCFE+
I, *+B K*:)+<0@$6.$%$D+<%+*7-< &5/>1,5.%G !1>+2?45%H CYCLE%DE
#+(L
(;:4DC?CD43@EC KGK %7-
#+(%N%LKREBS QRGD>@ESDTA<D@:<=
%7- 7%7- %7- QRGD>@ESD:4DCFE+ CD@?=6$B?)#?-F$>0=E
KGK $B +4DC?CD43@EC +B
#+(L
FGDCEI;4@E9 ''''%7-
*+E174* *+B (;:4DC?CD43@EC +B
!*)#?-(-?#"6$-D)#?- %7-
/6)%+H"6)+<
FE+!% $@;:4DC?CD43@EC $@;:4DC?CD43@EC $@;:4DC?CD43@EC
B9C9%D4,. 'M<;66A':>;J=ASO
&5/>1,5.%G !1>+2?45%H
F&
*E9E+4DC?CD43@EC'L'7'+B
0.
K*:)+<0:)%#6")/*A'<
%7-
$@;:4DC?CD43@EC
'M;9<=6<;9O V3?AC:<;E9':CCE6<3@;HA=
,%L?.<+006"('-)/6*#<+
EMIF$>06"='#/)+<
HMGCoA%lyase
AcétylCoA carboxylase
METABOLISME%DU%CHOLESTEROL
CD@?=6$B?7'/?6)/<0=E
METABOLISME
LIPOLYSE
,%$?-F$>0@?=6)/)+<
>#?-F$>0/6)%+H"6)+<0N
BETA:OXYDATION
HELICE%DE%LYNEN
>#?-F$>0+?%/@"/)+<
GLYCOLYSE
J@*$-)+<
O)P<//<0#*/6)/<D.)-)/<D:?6'P)/<
PHOSPHORYLATION%OXYDATIVE
K*:)+<0@$6.$%$D+<%+*7-<
K*:)+<0@$6.$%$D+<%+*7-<
>#?-F$>0+?%/@"/)+<
.(.RFGEC=6<3@EC
%(.R4GEC=6<3@EC
J#&)
7E+1.%.5;<34G:<@2;,K>.
SYNTHESE%DES%VLDL
&5/>1,5.%H
!1>+2?45%G
BIOSYNTHESE DES ACIDES GRAS
HELICE DE WAKIL
&5/>1,5.%H
!1>+2?45%G
CETOLYSE
CETOGENESE
EMIF$>0+?%/@)+<
EMIF$>0+?%/@)+<
2ème tour et suivants
LIPOGENESE
>#*=<0(6)+0+?%/@)+<
I-?#"6$-QG0=E
SYNTHESE%DES%ACIDES%BILIAIRES
CYCLE%DE%KREBS%
CYCLE%DE%
KREBS%
*(I%
*(I%
*(I%
F"!'
+F0'
F"!'
+F0'
F"!'
+F0'
F"!'
+F0'
F"!'
+F0'
F"!'
+F0'
F"!'
+F0'
F"!'
+F0'
F"!'
+F0'
F"!'
+F0'
F"!'
+F0'
F"!'
+F0'
F"!'
+F0'
F"!'
+F0'
F;<@:<='
!A44;9:<='
!A44;9DCFE+'
'
1 / 1 100%
Study collections
La catégorie de ce document est-elle correcte?
Merci pour votre participation!

Faire une suggestion

Avez-vous trouvé des erreurs dans linterface ou les textes ? Ou savez-vous comment améliorer linterface utilisateur de StudyLib ? Nhésitez pas à envoyer vos suggestions. Cest très important pour nous !